Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Buchsbaum

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1986
Antigenic modulation by anti-CD5 immunotoxinsJ M Manske, D J Buchsbaum, S M Azemove, et al.
Progress in Experimental Tumor Research|January 1, 1974
Preferential in vivo localization of 125I-labeled antibody in a carcinogen-induced syngeneic rat tumorW F Bale, M A Contreras, M J Izzo, et al.
Cancer Research|February 1, 1992
Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibodyD J Buchsbaum, R L Wahl, S D Glenn, et al.
Cancer|February 1, 1994
Three-dimensional reconstruction of monoclonal antibody uptake in tumor and calculation of beta dose-rate nonuniformityP L Roberson, D B Heidorn, M L Kessler, et al.
Cancer Research|April 1, 1991
Radiotherapy in mice with yttrium-90-labeled anti-Ly1 monoclonal antibody: therapy of established graft-versus-host disease induced across the major histocompatibility barrierD A Vallera, H Schmidberger, D J Buchsbaum, et al.
Gene Therapy|February 24, 1998
Use of a novel cross-linking method to modify adenovirus tropismB E Rogers, J T Douglas, C Ahlem, et al.
Cancer|March 15, 1991
18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomographyR L Wahl, G D Hutchins, D J Buchsbaum, et al.
Blood|July 27, 2000
Molecular modification of a recombinant anti-CD3epsilon-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine modelD A Vallera, D W Kuroki, A Panoskaltsis-Mortari, et al.
Cancer Gene Therapy|August 6, 2005
Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicityS A Kaliberov, S Chiz, L N Kaliberova, et al.
Cancer|December 24, 1997
Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vectorB E Rogers, D T Curiel, M S Mayo, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1986
Antigenic modulation by anti-CD5 immunotoxinsJ M Manske, D J Buchsbaum, S M Azemove, et al.
Progress in Experimental Tumor Research|January 1, 1974
Preferential in vivo localization of 125I-labeled antibody in a carcinogen-induced syngeneic rat tumorW F Bale, M A Contreras, M J Izzo, et al.
Cancer Research|February 1, 1992
Improved delivery of radiolabeled anti-B1 monoclonal antibody to Raji lymphoma xenografts by predosing with unlabeled anti-B1 monoclonal antibodyD J Buchsbaum, R L Wahl, S D Glenn, et al.
Cancer|February 1, 1994
Three-dimensional reconstruction of monoclonal antibody uptake in tumor and calculation of beta dose-rate nonuniformityP L Roberson, D B Heidorn, M L Kessler, et al.
Cancer Research|April 1, 1991
Radiotherapy in mice with yttrium-90-labeled anti-Ly1 monoclonal antibody: therapy of established graft-versus-host disease induced across the major histocompatibility barrierD A Vallera, H Schmidberger, D J Buchsbaum, et al.
Gene Therapy|February 24, 1998
Use of a novel cross-linking method to modify adenovirus tropismB E Rogers, J T Douglas, C Ahlem, et al.
Cancer|March 15, 1991
18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomographyR L Wahl, G D Hutchins, D J Buchsbaum, et al.
Blood|July 27, 2000
Molecular modification of a recombinant anti-CD3epsilon-directed immunotoxin by inducing terminal cysteine bridging enhances anti-GVHD efficacy and reduces organ toxicity in a lethal murine modelD A Vallera, D W Kuroki, A Panoskaltsis-Mortari, et al.
Cancer Gene Therapy|August 6, 2005
Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicityS A Kaliberov, S Chiz, L N Kaliberova, et al.
Cancer|December 24, 1997
Tumor localization of a radiolabeled bombesin analogue in mice bearing human ovarian tumors induced to express the gastrin-releasing peptide receptor by an adenoviral vectorB E Rogers, D T Curiel, M S Mayo, et al.
Pageof 10